Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Putoczki

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|December 29, 2017
Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent MechanismVirginie Deswaerte, Paul Nguyen, Alison West, et al.
Nature Immunology|November 24, 2015
Complementarity and redundancy of IL-22-producing innate lymphoid cellsLucille C Rankin, Mathilde J H Girard-Madoux, Cyril Seillet, et al.
Oncotarget|April 19, 2017
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinomaRhiannon Coulson, Seng H Liew, Angela A Connelly, et al.
Cell|June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during TumorigenesisPaul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Nature|November 22, 2017
IL-11 is a crucial determinant of cardiovascular fibrosisSebastian Schafer, Sivakumar Viswanathan, Anissa A Widjaja, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancer Research|December 29, 2017
Inflammasome Adaptor ASC Suppresses Apoptosis of Gastric Cancer Cells by an IL18-Mediated Inflammation-Independent MechanismVirginie Deswaerte, Paul Nguyen, Alison West, et al.
Nature Immunology|November 24, 2015
Complementarity and redundancy of IL-22-producing innate lymphoid cellsLucille C Rankin, Mathilde J H Girard-Madoux, Cyril Seillet, et al.
Oncotarget|April 19, 2017
The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinomaRhiannon Coulson, Seng H Liew, Angela A Connelly, et al.
Cell|June 19, 2018
Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during TumorigenesisPaul K Ziegler, Julia Bollrath, Charles K Pallangyo, et al.
The Journal of Experimental Medicine|February 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signalingStefanie Schmidt, Neele Schumacher, Jeanette Schwarz, et al.
Nature|November 22, 2017
IL-11 is a crucial determinant of cardiovascular fibrosisSebastian Schafer, Sivakumar Viswanathan, Anissa A Widjaja, et al.
Pageof 3